Unveiling Ketamine's Influence on Astrocytic Kir4.1 Channels Through Multimodal Analysis: Confocal Microscopy, Immunocytochemistry, Fluorescence Analysis, and Electrophysiology.
Samo Pirnat, Katja Fink, Matjaž Stenovec, Marko Kreft, Robert Zorec
Methods in molecular biology (Clifton, N.J.) January 1, 2025 DOI: 10.1007/978-1-0716-4366-2_20 via PubMed
Summary
AI-generated from the abstractKetamine, an antidepressant for major depressive disorder, alters the dynamics of the potassium channel Kir4.1 in astrocytes. Using cultured rat and mouse astrocytes, the authors tracked fluorescently labeled Kir4.1 vesicles and measured surface density and currents after ketamine exposure. The findings suggest that ketamine modulates Kir4.1 trafficking and activity, which could influence extracellular potassium levels and neuronal excitability. This mechanism may contribute to ketamine's therapeutic effects in depression, offering a cellular-level explanation for its rapid antidepressant action.
Study at a glance
| Characteristics | Multifaceted investigation Peer reviewed |
|---|---|
| Population | Cultured rat and mouse cortical astrocytes |
| Intervention | Ketamine |
| Topics | Ketamine |
| Keywords | Astrocytes Confocal microscopy Electrophysiology Kir4.1 |
| Key finding | Ketamine modulates the dynamics, surface density, and voltage-activated currents of the Kir4.1 potassium channel in astrocytes. |
Abstract
Understanding the elusive mechanisms responsible for the therapeutic efficacy of ketamine in major depressive disorder (MDD) is crucial. Astrocytes play a vital role in regulating extracellular potassium concentration ([K+]o), which is essential for maintaining proper neuronal excitability and overall brain function. Dysregulation of [K+]o can lead to significant changes in neuronal activity, potentially contributing to the pathophysiology of various neurological and psychiatric conditions, including depression. To this end, we conducted a multifaceted investigation to elucidate the effects of ketamine on the inwardly rectifying K+ channel Kir4.1, which is critical for neuronal excitability and K+ homeostasis. Using cultured rat cortical astrocytes expressing fluorescently labeled Kir4.1 (Kir4.1-EGFP), we followed the dynamics of Kir4.1-EGFP vesicles after ketamine exposure. In addition, using live cell immunolabeling and patch-clamp assays in cultured mouse astrocytes, we investigated the effects of ketamine on Kir4.1 surface density and voltage-activated currents, similar to Ba2+ inhibition. This comprehensive methodological approach sheds light on the modulation of Kir4.1 dynamics by ketamine and thus provides valuable insights into its therapeutic mechanisms in MDD.